Behavioral training rescues motor deficits in Cyfip1 haploinsufficiency mouse model of Autism Spectrum Disorders

Bachmann, Sven ORCID: https://orcid.org/0000-0002-7917-5799, Sledziowska, Monika Teresa, Cross, Ellen, Kalbassi, Shireene, Waldron, Sophie, Ranson, Adam ORCID: https://orcid.org/0000-0002-4804-0832 and Baudouin, Stephane ORCID: https://orcid.org/0000-0001-6902-6071 2019. Behavioral training rescues motor deficits in Cyfip1 haploinsufficiency mouse model of Autism Spectrum Disorders. Translational Psychiatry 9 (29) 10.1038/s41398-018-0338-9

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (1MB) | Preview

Abstract

Deletions in the 15q11.2 region of the human genome are associated with neurobehavioral deficits, and motor development delay, as well as in some cases, symptoms of autism or schizophrenia. The cytoplasmic FMRP-interacting protein 1 (CYFIP1) is one of the four genes contained within this locus and has been associated with other genetic forms of autism spectrum disorders (ASD). In mice, Cyfip1 haploinsufficiency leads to alteration of dendritic spine morphology and defects in synaptic plasticity, two pathophysiological hallmarks of mouse models of ASD. At the behavioral level, however, Cyfip1 haploinsufficiency leads to minor phenotypes, not directly relevant for 15q11.2 deletion syndrome or ASD. A fundamental question is whether neuronal phenotypes caused by the mutation of Cyfip1 are relevant for the human condition. Here, we describe a synaptic cluster of ASD-associated proteins centered on CYFIP1 and the adhesion protein Neuroligin-3. Cyfip1 haploinsufficiency in mice led to decreased dendritic spine density and stability associated with social behavior and motor learning phenotypes. Behavioral training early in development resulted in alleviating the motor learning deficits caused by Cyfip1 haploinsufficiency. Altogether, these data provide new insight into the neuronal and behavioral phenotypes caused by Cyfip1 mutation and proof-of-concept for the development of a behavioral therapy to treat phenotypes associated with 15q11.2 syndromes and ASD.

Item Type:	Article
Date Type:	Published Online
Status:	Published
Schools:	Biosciences Medicine
Publisher:	Nature Publishing Group
ISSN:	2158-3188
Funders:	Wellcome Trust
Date of First Compliant Deposit:	26 November 2018
Date of Acceptance:	25 November 2018
Last Modified:	10 Feb 2024 02:17
URI:	https://orca.cardiff.ac.uk/id/eprint/117097

Citation Data

Cited 11 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item